Related Experiment Video
Updated: Jun 12, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Immediate serum growth hormone decrease as a potential index of dopamine-related response to electroconvulsive
Francesca Pacitti1, Angela Iannitelli, Maria Caredda
1Department of Science of Health, University of L'Aquila, Italy. francesca.pacitti@cc.univaq.it
The Journal of ECT
|June 22, 2010
Summary
Electroconvulsive therapy (ECT) significantly decreased growth hormone (GH) levels in schizophrenia patients, suggesting a dopamine-mediated response. These GH changes may indicate treatment effectiveness and potential antidopaminergic actions of ECT.
Area of Science:
- Neuroscience
- Psychiatry
- Endocrinology
Background:
- Schizophrenia is a complex psychiatric disorder often treated with electroconvulsive therapy (ECT).
- Dopamine pathways are implicated in both schizophrenia pathophysiology and growth hormone (GH) regulation.
- The immediate effects of ECT on serum GH levels in schizophrenia patients remain incompletely understood.
Purpose of the Study:
- To investigate the acute impact of electroconvulsive therapy (ECT) on dopamine-regulated growth hormone (GH) levels in individuals with schizophrenia.
- To examine how serum GH levels change throughout a course of therapeutic ECT sessions.
Main Methods:
- Serum GH levels were measured in 11 male schizophrenia patients undergoing 8 bilateral ECT sessions.
- Measurements were taken pre-ECT, during ECT, and 15 and 30 minutes post-ECT.
- These measurements were collected during the first, fourth, and eighth ECT sessions.
Main Results:
- A significant reduction in serum GH levels was observed 15 and 30 minutes after ECT at the fourth and eighth sessions.
- No significant changes in baseline GH levels were noted during or after the treatment course.
- Clinical improvement in schizophrenia symptoms correlated with reduced Positive and Negative Syndrome Scale scores.
Conclusions:
- Immediate post-ECT GH level decreases may serve as an indicator of dopamine-mediated therapeutic response.
- GH reduction could be linked to the antidopaminergic effects of ECT.
- Further research is necessary to elucidate the precise relationship between dopamine system instability, GH regulation, and ECT response in schizophrenia.
More Related Videos
Related Concept Videos
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...